Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE3
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
- Status
- COMPLETED
- Phase
- N/A
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
- Status
- COMPLETED
- Phase
- PHASE3
WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes
- Status
- COMPLETED
- Phase
- N/A
Trial of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) in Older Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment
- Status
- UNKNOWN
- Phase
- PHASE3
Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Investigation of Topical SB705498 on Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia
- Status
- TERMINATED
- Phase
- PHASE4
Pharmacokinetic Study of 4 mg Nicotine Lozenge.
- Status
- COMPLETED
- Phase
- PHASE2
Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing
- Status
- COMPLETED
- Phase
- PHASE1
A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)
- Status
- COMPLETED
- Phase
- PHASE1
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
- Status
- TERMINATED
- Phase
- PHASE3
A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.
- Status
- COMPLETED
- Phase
- PHASE2
Belimumab in Remission of VASculitis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral Dose
- Status
- COMPLETED
- Phase
- PHASE1